Step 3. Preparation of the Joint Scientific Consultation report
Once accepted, each JSC becomes the responsibility of a subgroup designated by the Coordination Group (Article 18(1)).
This subgroup appoints an assessor and co-assessor from different Member States, based on relevant scientific expertise. Their role is to review documentation provided by the health technology developer and prepare a draft Joint Scientific Consultation report (Article 18(2-4)).
Other members of the designated subgroup may provide comments on the draft document and provide additional recommendations specific to their Member State (Article 18(5)). The subgroup will also ensure that patients, clinical experts and other relevant experts are given an opportunity to provide input during the preparation of the draft outcome document via a meeting between the health technology developer and patients, clinical experts, other relevant experts, and – if applicable – representatives of the European Medicines Agency or the expert panel involved in carrying out parallel consultations (Article 18(5-8)).
The assessor, assisted by the co-assessor, will consider all comments, finalise the draft joint scientific consultation report. This draft will then be submitted the Coordination Group for approval (Article 18(9-10).